Cure My Disease

Don't miss your cure!

 Log in / Sign up

New test could predict falls in muscle disease patients

NCT ID NCT06605612

ENROLLING_BY_INVITATION Diagnosis Sponsor: LMU Klinikum Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study aims to create a simple test battery to determine fall risk in people with neuromuscular disorders, such as muscular dystrophy or ALS. Researchers will assess 108 participants using several physical tests like walking, standing, and rising from a chair. The goal is to provide clear guidelines for when to use walking aids like canes or walkers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could provide a simple, standard way to assess fall risk and decide when a walking aid is needed for people with neuromuscular disorders.

What could go wrong

This is an early validation study with only 108 participants. The tests may not work for all types of neuromuscular disorders or may need further refinement.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POMPE DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

amyotrophic lateral sclerosis chronic inflammatory demyelinating polyradiculoneuropathy facioscapulohumeral muscular dystrophy Friedreich ataxia glycogen storage disease II Glycogen Storage Disease Type II Guillain-Barre syndrome hereditary motor and sensory neuropathy inclusion body myositis Lambert-Eaton myasthenic syndrome myasthenia gravis myotonic dystrophy neuromuscular disease spinal muscular atrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AMYOTROPHIC LATERAL SCLEROSIS CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY FRIEDREICH ATAXIA GUILLAIN BARRÉ SYNDROME HEREDITARY MOTOR SENSORY NEUROPATHY INCLUSION BODY MYOSITIS LAMBERT-EATON-SYNDROME LIMB-GIRDLE AND FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHIES MYASTHENIA GRAVIS MYOTONIC DYSTROPHY POMPE DISEASE SPINAL MUSCULAR ATROPHY

Contacts and locations

Locations

  • Friedrich-Baur-Institut, Neurologische Klinik und Poliklinik, LMU Klinikum, Ludwig-Maximilians-Universität München

    München, Bavaria, 80336, Germany